Lojaimiess Kit
Product Images NDC 70700-124

This is a description of an extended-cycle oral contraceptive product in which one unit or dispenser contains 91 tablets, comprising of 84 orange tablets, each containing 0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol, and 7 yellow tablets, each containing 0.01 mg ethinyl estradiol. It explicitly states that the product is intended to prevent pregnancy but does not protect against HIV infection or other sexually transmitted diseases. The recommended dosage is one orange tablet per day for four consecutive days, followed by one yellow tablet for the consequent seven days as per a prescribed schedule. The package label also provides information about storage conditions.*

This appears to be a chart showing the percentage of bleeding and/or spotting occurring during different cycles over a span of 364 days. There were 848 participants in the first cycle and 574 in the fourth cycle.*

This text appears to be a chart comparing different methods of birth control and their effectiveness in preventing pregnancy. It indicates the number of pregnancies per 100 women in one year for each method. The most effective forms are listed at the top, including sterilization, intrauterine devices, birth control implants, and injections. Less effective methods such as birth control pills, condoms, and withdrawal are listed below. The chart also mentions the possibility of not having sex during the most fertile days of the monthly cycle, using spermicide, or using a diaphragm. However, the text at the bottom is cut off and therefore the chart may not provide the full information on all methods.*

Ethinyl Estradiol is a compound with the molecular formula C20H24O2 and a molecular weight of 296.4. It is commonly used as a medication in hormonal birth control pills.*